Clinical Trial Update: NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer [NA]

View source ↗

Summary

Clinical trial update describing first-line treatment options for locally advanced pancreatic cancer, comparing NALIRIFOX with PD-1 sequential radiotherapy to A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Abraxane (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)
• Onivyde (nal-IRI) (nanoliposomal irinotecan)
• PD-1 inhibitor

Snippet

Sponsor: Du Juan | Conditions: Locally Advanced Pancreatic Cancer | NA | Status: RECRUITING